{"title":"早期精神分裂症的认知疗法和洞察力：一项系统综述。","authors":"Bastien Houdebine, Natacha Rondeau, Chrystel Besche-Richard","doi":"10.1016/j.encep.2025.05.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This systematic review aims to evaluate the impact of cognitive-behavioral and metacognitive therapies on cognitive and clinical insight into early schizophrenia disease.</p><p><strong>Methods: </strong>A comprehensive literature review was conducted across several databases, including Pubmed, PsycINFO, and Cochrane Library, focusing on studies published between 2006 and May 2024. The studies selected for this review were either randomized controlled trials (RCTs), cross-sectional studies, or exploratory studies.</p><p><strong>Results: </strong>Nine studies were included (7 RCTs, one cross-sectional study, and one exploratory study), using various tools to assess cognitive and clinical insight. The findings showed mixed results: cognitive-behavioral therapy (CBT) and metacognitive therapies (MCT) demonstrated varied outcomes. Some studies reported improvements in self-reflection and self-certainty, two facets of cognitive insight, especially in young patients.</p><p><strong>Conclusions: </strong>This study highlights the complexity of the relationship between different therapies and insight improvement in early schizophrenia. This result emphasizes the need for additional studies to improve our understanding of the effects of cognitive therapies, given that the current number of studies is too limited to draw conclusions. Future research should focus on developing more personalized and effective treatment strategies to better address the individual needs of young patients.</p>","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cognitive therapies and insight in early schizophrenia: A systematic review.\",\"authors\":\"Bastien Houdebine, Natacha Rondeau, Chrystel Besche-Richard\",\"doi\":\"10.1016/j.encep.2025.05.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>This systematic review aims to evaluate the impact of cognitive-behavioral and metacognitive therapies on cognitive and clinical insight into early schizophrenia disease.</p><p><strong>Methods: </strong>A comprehensive literature review was conducted across several databases, including Pubmed, PsycINFO, and Cochrane Library, focusing on studies published between 2006 and May 2024. The studies selected for this review were either randomized controlled trials (RCTs), cross-sectional studies, or exploratory studies.</p><p><strong>Results: </strong>Nine studies were included (7 RCTs, one cross-sectional study, and one exploratory study), using various tools to assess cognitive and clinical insight. The findings showed mixed results: cognitive-behavioral therapy (CBT) and metacognitive therapies (MCT) demonstrated varied outcomes. Some studies reported improvements in self-reflection and self-certainty, two facets of cognitive insight, especially in young patients.</p><p><strong>Conclusions: </strong>This study highlights the complexity of the relationship between different therapies and insight improvement in early schizophrenia. This result emphasizes the need for additional studies to improve our understanding of the effects of cognitive therapies, given that the current number of studies is too limited to draw conclusions. Future research should focus on developing more personalized and effective treatment strategies to better address the individual needs of young patients.</p>\",\"PeriodicalId\":51042,\"journal\":{\"name\":\"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-09-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.encep.2025.05.009\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.encep.2025.05.009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Cognitive therapies and insight in early schizophrenia: A systematic review.
Objectives: This systematic review aims to evaluate the impact of cognitive-behavioral and metacognitive therapies on cognitive and clinical insight into early schizophrenia disease.
Methods: A comprehensive literature review was conducted across several databases, including Pubmed, PsycINFO, and Cochrane Library, focusing on studies published between 2006 and May 2024. The studies selected for this review were either randomized controlled trials (RCTs), cross-sectional studies, or exploratory studies.
Results: Nine studies were included (7 RCTs, one cross-sectional study, and one exploratory study), using various tools to assess cognitive and clinical insight. The findings showed mixed results: cognitive-behavioral therapy (CBT) and metacognitive therapies (MCT) demonstrated varied outcomes. Some studies reported improvements in self-reflection and self-certainty, two facets of cognitive insight, especially in young patients.
Conclusions: This study highlights the complexity of the relationship between different therapies and insight improvement in early schizophrenia. This result emphasizes the need for additional studies to improve our understanding of the effects of cognitive therapies, given that the current number of studies is too limited to draw conclusions. Future research should focus on developing more personalized and effective treatment strategies to better address the individual needs of young patients.
期刊介绍：
Une revue française de renommée internationale.
- Un comite de rédaction représentant tous les aspects de la prise en charge psychiatrique du patient.
- Une sélection rigoureuse d''articles faisant l''objet de plusieurs expertises.
- Des travaux d''auteurs et de chercheurs de renommée internationale.
- Des indexations dans les grandes bases de données (Current Contents, Excerpta Medica, etc.).
- Un facteur d''impact qui témoigne de la grande notoriété de la revue.
La tribune des publications originales de haut niveau.
- Une très grande diversité des sujets traités, rigoureusement sélectionnés à travers des sommaires dynamiques :
- des éditoriaux de médecins référents,
- une revue de presse sur les actualités internationales,
- des articles originaux pour approfondir vos connaissances,
- des mises au point et des cas cliniques pour engager votre réflexion sur les indications et choix possibles au travers de mises en situation clinique,
- des dossiers thématiques pour faire le tour d''une question.
- L''actualité de l''AFPB : L''Encéphale publie régulièrement des comptes rendus de l''Association française de psychiatrie clinique.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
